These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 9806936)
1. Prion protein fragments spanning helix 1 and both strands of beta sheet (residues 125-170) show evidence for predominantly helical propensity by CD and NMR. Sharman GJ; Kenward N; Williams HE; Landon M; Mayer RJ; Searle MS Fold Des; 1998; 3(5):313-20. PubMed ID: 9806936 [TBL] [Abstract][Full Text] [Related]
2. Peptides and proteins in neurodegenerative disease: helix propensity of a polypeptide containing helix 1 of the mouse prion protein studied by NMR and CD spectroscopy. Liu A; Riek R; Zahn R; Hornemann S; Glockshuber R; Wüthrich K Biopolymers; 1999; 51(2):145-52. PubMed ID: 10397798 [TBL] [Abstract][Full Text] [Related]
3. Conformational polymorphism of the amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. De Gioia L; Selvaggini C; Ghibaudi E; Diomede L; Bugiani O; Forloni G; Tagliavini F; Salmona M J Biol Chem; 1994 Mar; 269(11):7859-62. PubMed ID: 7907586 [TBL] [Abstract][Full Text] [Related]
4. Conformational properties of peptide fragments homologous to the 106-114 and 106-126 residues of the human prion protein: a CD and NMR spectroscopic study. Di Natale G; Impellizzeri G; Pappalardo G Org Biomol Chem; 2005 Feb; 3(3):490-7. PubMed ID: 15678187 [TBL] [Abstract][Full Text] [Related]
5. Exploring the propensities of helices in PrP(C) to form beta sheet using NMR structures and sequence alignments. Dima RI; Thirumalai D Biophys J; 2002 Sep; 83(3):1268-80. PubMed ID: 12202354 [TBL] [Abstract][Full Text] [Related]
7. Conformational polymorphism of the amyloidogenic peptide homologous to residues 113-127 of the prion protein. Satheeshkumar KS; Jayakumar R Biophys J; 2003 Jul; 85(1):473-83. PubMed ID: 12829502 [TBL] [Abstract][Full Text] [Related]
8. NMR structure of the mouse prion protein domain PrP(121-231). Riek R; Hornemann S; Wider G; Billeter M; Glockshuber R; Wüthrich K Nature; 1996 Jul; 382(6587):180-2. PubMed ID: 8700211 [TBL] [Abstract][Full Text] [Related]
9. Spectroscopic characterization of conformational differences between PrPC and PrPSc: an alpha-helix to beta-sheet transition. Baldwin MA; Pan KM; Nguyen J; Huang Z; Groth D; Serban A; Gasset M; Mehlhorn I; Fletterick RJ; Cohen FE Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):435-41. PubMed ID: 7913763 [TBL] [Abstract][Full Text] [Related]
10. A scrapie-like unfolding intermediate of the prion protein domain PrP(121-231) induced by acidic pH. Hornemann S; Glockshuber R Proc Natl Acad Sci U S A; 1998 May; 95(11):6010-4. PubMed ID: 9600908 [TBL] [Abstract][Full Text] [Related]
11. Clustered negative charges on the lipid membrane surface induce beta-sheet formation of prion protein fragment 106-126. Miura T; Yoda M; Takaku N; Hirose T; Takeuchi H Biochemistry; 2007 Oct; 46(41):11589-97. PubMed ID: 17887730 [TBL] [Abstract][Full Text] [Related]
12. Folding and intrinsic stability of deletion variants of PrP(121-231), the folded C-terminal domain of the prion protein. Eberl H; Glockshuber R Biophys Chem; 2002 May; 96(2-3):293-303. PubMed ID: 12034448 [TBL] [Abstract][Full Text] [Related]
13. Assemblages of prion fragments: novel model systems for understanding amyloid toxicity. Satheeshkumar KS; Murali J; Jayakumar R J Struct Biol; 2004 Nov; 148(2):176-93. PubMed ID: 15477098 [TBL] [Abstract][Full Text] [Related]
14. CD and NMR studies of prion protein (PrP) helix 1. Novel implications for its role in the PrPC-->PrPSc conversion process. Ziegler J; Sticht H; Marx UC; Müller W; Rösch P; Schwarzinger S J Biol Chem; 2003 Dec; 278(50):50175-81. PubMed ID: 12952977 [TBL] [Abstract][Full Text] [Related]
15. Prion protein (PrP) synthetic peptides induce cellular PrP to acquire properties of the scrapie isoform. Kaneko K; Peretz D; Pan KM; Blochberger TC; Wille H; Gabizon R; Griffith OH; Cohen FE; Baldwin MA; Prusiner SB Proc Natl Acad Sci U S A; 1995 Nov; 92(24):11160-4. PubMed ID: 7479957 [TBL] [Abstract][Full Text] [Related]
16. Conformational transitions in peptides containing two putative alpha-helices of the prion protein. Zhang H; Kaneko K; Nguyen JT; Livshits TL; Baldwin MA; Cohen FE; James TL; Prusiner SB J Mol Biol; 1995 Jul; 250(4):514-26. PubMed ID: 7542350 [TBL] [Abstract][Full Text] [Related]
17. Comparative computational analysis of prion proteins reveals two fragments with unusual structural properties and a pattern of increase in hydrophobicity associated with disease-promoting mutations. Kuznetsov IB; Rackovsky S Protein Sci; 2004 Dec; 13(12):3230-44. PubMed ID: 15557265 [TBL] [Abstract][Full Text] [Related]
18. Influence of pH on NMR structure and stability of the human prion protein globular domain. Calzolai L; Zahn R J Biol Chem; 2003 Sep; 278(37):35592-6. PubMed ID: 12826672 [TBL] [Abstract][Full Text] [Related]
19. Aggregation and fibrillization of the recombinant human prion protein huPrP90-231. Swietnicki W; Morillas M; Chen SG; Gambetti P; Surewicz WK Biochemistry; 2000 Jan; 39(2):424-31. PubMed ID: 10631004 [TBL] [Abstract][Full Text] [Related]
20. Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure. Cobb NJ; Sönnichsen FD; McHaourab H; Surewicz WK Proc Natl Acad Sci U S A; 2007 Nov; 104(48):18946-51. PubMed ID: 18025469 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]